Evidence map›Paper›PMID 21507973›Full record

ArticleJournal of virology2011

Capturing the herpes simplex virus core fusion complex (gB-gH/gL) in an acidic environment.

Tina M Cairns, J Charles Whitbeck, Huan Lou, Ekaterina E Heldwein, Tirumala K Chowdary, Roselyn J Eisenberg, Gary H Cohen

Abstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Allosteric mechanism of membrane fusion activation in a herpesvirus.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Optineurin in ocular herpes infection.Experimental eye research · 2022
    Review
  8. Article
  9. Review
  10. Entry of Alphaherpesviruses.Current issues in molecular biology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Herpes Simplex Virus Cell Entry Mechanisms: An Update.Frontiers in cellular and infection microbiology · 2020
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Herpes simplex virus Membrane Fusion.Advances in anatomy, embryology, and cell biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tina M CairnsDepartment of Microbiology, University of Pennsylvania, 4010 Locust St., Levy Rm. 233, Philadelphia, PA 19104, USA. tmcairns@biochem.dental.upenn.edu
J Charles Whitbeck
Huan Lou
Ekaterina E Heldwein
Tirumala K Chowdary
Roselyn J Eisenberg
Gary H Cohen

Funding

Studies of Herpes Simplex Virus GlycoproteinsR37AI018289 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COHEN, GARY H · 2005 to 2014
$3.9M
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINSR01AI018289 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COHEN, GARY H · 1985 to 2019
$3.8M
Uncovering the Regulatory Role of gH/gL in HSV FusionR01AI056045 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROSELYN J · 2004 to 2015
$3.7M
Structural and mechanistic studies of herpesvirus entry into host cellsDP2OD001996 · OD · TUFTS UNIVERSITY BOSTON · PI HELDWEIN, EKATERINA · 2007 to 2007
$2.5M
EARLY EVENTS IN HERPES SIMPLEX VIRUS ENTRYR01NS036731 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROSELYN J · 1997 to 2006
$2.4M
Early Events in Herpes Simplex Virus EntryR01AI076231 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROSELYN J · 2008 to 2012
$1.9M
Study of the structure, function and regulation of gB, the fusion protein of HSVR56AI076231 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROSELYN J · 2013 to 2013
$362k
HSV-Receptor Interaction in Entry and PathogenesisR21AI056045 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROSELYN J. · 2003 to 2003
$310k
NIAID NIH HHS AI-05645NIAID NIH HHS AI-076231NIAID NIH HHS AI-18289NIAID NIH HHS R01 AI018289NIAID NIH HHS R01 AI056045NIAID NIH HHS R01 AI076231NIAID NIH HHS R21 AI056045NIAID NIH HHS R37 AI018289NIAID NIH HHS R56 AI076231NIH HHS DP2 OD001996NINDS NIH HHS R01 NS036731
6 · The paper itself

Abstract

Herpes simplex virus (HSV) entry requires the core fusion machinery of gH/gL and gB as well as gD and a gD receptor. When gD binds receptor, it undergoes conformational changes that presumably activate gH/gL, which then activates gB to carry out fusion. gB is a class III viral fusion protein, while gH/gL does not resemble any known viral fusion protein. One hallmark of fusion proteins is their ability to bind lipid membranes. We previously used a liposome coflotation assay to show that truncated soluble gB, but not gH/gL or gD, can associate with liposomes at neutral pH. Here, we show that gH/gL cofloats with liposomes but only when it is incubated with gB at pH 5. When gB mutants with single amino acid changes in the fusion loops (known to inhibit the binding of soluble gB to liposomes) were mixed with gH/gL and liposomes at pH 5, gH/gL failed to cofloat with liposomes. These data suggest that gH/gL does not directly associate with liposomes but instead binds to gB, which then binds to liposomes via its fusion loops. Using monoclonal antibodies, we found that many gH and gL epitopes were altered by low pH, whereas the effect on gB epitopes was more limited. Our liposome data support the concept that low pH triggers conformational changes to both proteins that allow gH/gL to physically interact with gB.

Indexed as

AnimalsBaculoviridaeCells, CulturedCrystallizationGenetic VectorsHydrogen-Ion ConcentrationLiposomesModels, MolecularSimplexvirusSpodopteraViral Envelope Proteinsglycoprotein B, Simplexvirusglycoprotein H, herpes simplex virus type 1glycoprotein L, Human herpesvirus 1LiposomesViral Envelope Proteins

Identifiers

PMID21507973
PMCPMC3126480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.